Library · Markets
Live + DailyFive market questions. Five honest tools.
Start with the question you are actually trying to answer: What is it trading at? Is the business improving? Did an overnight setup survive the filters? We show the source and date, keep the misses, and leave a blank whenever the data cannot support a number.
- NightlyIEX EOD bars + SEC EDGAR + GDELT
Signal Desk
Did anything earn a place on the watchlist?
The overnight desk tries five price setups across the eligible stock universe. A name only reaches the page if its history beats the stock’s normal up-rate, survives trading costs and still looks sane on newer, unseen data. The local model can reject a survivor, but it cannot promote one.
Empty nights count. Rejections stay visible. Nothing is turned into a buy button.
- DailySEC EDGAR + Alpaca (IEX feed)
Daily Dashboard
Which recent filings look strongest on paper?
Twenty companies with the strongest nine-part Piotroski filing scores, with a three-year IEX chart beside each one. RSI and the 200-day average are context. The useful number is whether that simple trend filter beat the stock’s own normal five-day result — and usually it did not.
36 companies currently score 7/9 or better with at least eight reported inputs. Strong filing, not necessarily cheap stock.
- LiveIEX via Alpaca · Coinbase · ECB
Stock & Market Analyzer
What is this trading at right now?
A compact tape for IEX-listed stocks, Coinbase crypto and ECB currency reference rates. Every row says what kind of price it is, where it came from and how old it is. A stale one-sided quote is labelled that way instead of being dressed up as a live market price.
The site supplies polled IEX snapshots. Your own Alpaca key is optional if you want the direct real-time stream.
- DailySEC EDGAR XBRL
Quality Screener
Which businesses improved in the latest filings?
A filing-only ranking across profitability, leverage and operating efficiency. Each score opens up into nine pass/fail/missing marks, so you can tell the difference between a complete 8/9 and a flattering score built on sparse data.
No price, no valuation and no timing call. This page only reads the accounts.
- DailySEC EDGAR filings + XBRL
OTC Integrity Screener
Where are the obvious filing and dilution problems?
The opposite of a penny-stock tip sheet: companies that stopped filing, expanded the share count sharply or reported very little cash runway. These are mechanical flags from the filings, not accusations and not a list of shorts.
1,757 OTC tickers covered; 2,495 across all venues file no XBRL financials at all.
Why the data menu is shorter than you might expect
Most “free stock APIs” are free for one person looking at one screen. Their terms do not let a public site republish the feed. We would rather run a smaller, clearly sourced desk than build on a key that can be shut off for using it in public.
So the public pages use sources we can name without squinting at the licence:IEX venue quotes,Coinbase's public exchange feed,ECB reference rates andSEC EDGAR filings. The nightly research archive has more feeds, but only licensing-clean aggregates make it back to the site.
That choice has a real trade-off. IEX is one exchange, roughly 2.5% of US volume. Its prices usually track the wider market closely, but they are not the official consolidated last trade. OTC shares do not trade there at all.
There is also no price on either filing screener. We could bolt on an unofficial quote, but that would make the page look more complete while making the evidence worse. Those tools stick to the question the filings can answer.
Screener data generated from8,002 SEC filers. These pages make no external requests when you load them; the analyzer connects only to the feeds named on it.
How to read the desk
A research notebook, not a tip sheet.
A backtest percentage never stands alone here. We put it next to the stock’s ordinary result, the number of times the setup fired and a plausible range around the estimate. We also count every factor we screened, including the ones that failed. If a process always finds an edge, it is probably grading its own homework.
None of this knows your time horizon, taxes, cash needs or tolerance for a bad month. It is not a recommendation to buy, sell or hold. Think of it as a quant’s working paper: useful evidence, visible assumptions and plenty of room for the market to prove it wrong.